Vioxx rofecoxib: Phase IV data; marketed to treat osteoarthritis and pain

MRK published in The New England Journal of Medicine previously reported results of

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE